These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
233 related articles for article (PubMed ID: 23059545)
1. Design, synthesis and 3D-QSAR analysis of novel 2-hydrazinyl-4-morpholinothieno[3,2-d]pyrimidine derivatives as potential antitumor agents. Zhu W; Liu Y; Zhai X; Wang X; Zhu Y; Wu D; Zhou H; Gong P; Zhao Y Eur J Med Chem; 2012 Nov; 57():162-75. PubMed ID: 23059545 [TBL] [Abstract][Full Text] [Related]
2. Design, synthesis and biological evaluation of novel thieno[3,2-d]pyrimidine derivatives containing diaryl urea moiety as potent antitumor agents. Liu Z; Wang Y; Lin H; Zuo D; Wang L; Zhao Y; Gong P Eur J Med Chem; 2014 Oct; 85():215-27. PubMed ID: 25086238 [TBL] [Abstract][Full Text] [Related]
3. Synthesis and biological evaluation of novel 6-hydrazinyl-2,4-bismorpholino pyrimidine and 1,3,5-triazine derivatives as potential antitumor agents. Zhu W; Liu Y; Zhao Y; Wang H; Tan L; Fan W; Gong P Arch Pharm (Weinheim); 2012 Oct; 345(10):812-21. PubMed ID: 22707438 [TBL] [Abstract][Full Text] [Related]
4. Synthesis of novel pyrazolo[3,4-d]pyrimidine derivatives as potential anti-breast cancer agents. Abd El Hamid MK; Mihovilovic MD; El-Nassan HB Eur J Med Chem; 2012 Nov; 57():323-8. PubMed ID: 23085106 [TBL] [Abstract][Full Text] [Related]
5. Novel Pyrazolo[3,4-d]pyrimidines as Potential Cytotoxic Agents: Design, Synthesis, Molecular Docking and CDK2 Inhibition. Maher M; Kassab AE; Zaher AF; Mahmoud Z Anticancer Agents Med Chem; 2019; 19(11):1368-1381. PubMed ID: 31038080 [TBL] [Abstract][Full Text] [Related]
6. Design, synthesis, and quantitative structure-activity relationship of cytotoxic gamma-carboline derivatives. Chen J; Dong X; Liu T; Lou J; Jiang C; Huang W; He Q; Yang B; Hu Y Bioorg Med Chem; 2009 May; 17(9):3324-31. PubMed ID: 19359185 [TBL] [Abstract][Full Text] [Related]
7. Design, synthesis and biological evaluation of novel thieno[3,2-d]pyrimidine derivatives possessing diaryl semicarbazone scaffolds as potent antitumor agents. Liu Z; Wu S; Wang Y; Li R; Wang J; Wang L; Zhao Y; Gong P Eur J Med Chem; 2014 Nov; 87():782-93. PubMed ID: 25440879 [TBL] [Abstract][Full Text] [Related]
8. Synthesis, anticancer activity and effects on cell cycle profile and apoptosis of novel thieno[2,3-d]pyrimidine and thieno[3,2-e] triazolo[4,3-c]pyrimidine derivatives. Kandeel MM; Refaat HM; Kassab AE; Shahin IG; Abdelghany TM Eur J Med Chem; 2015 Jan; 90():620-32. PubMed ID: 25499930 [TBL] [Abstract][Full Text] [Related]
9. Design, synthesis and anticancer activity of 4-morpholinothieno[3,2-d]pyrimidine derivatives bearing arylmethylene hydrazine moiety. Zhu W; Zhai X; Fu Q; Guo F; Bai M; Wang J; Wang H; Gong P Chem Pharm Bull (Tokyo); 2012; 60(8):1037-45. PubMed ID: 22863708 [TBL] [Abstract][Full Text] [Related]
10. Design, synthesis, and SAR analysis of cytotoxic sinapyl alcohol derivatives. Zou HB; Dong SY; Zhou CX; Hu LH; Wu YH; Li HB; Gong JX; Sun LL; Wu XM; Bai H; Fan BT; Hao XJ; Stöckigt J; Zhao Y Bioorg Med Chem; 2006 Mar; 14(6):2060-71. PubMed ID: 16303311 [TBL] [Abstract][Full Text] [Related]
11. 6-Cinnamoyl-4-arylaminothienopyrimidines as highly potent cytotoxic agents: Design, synthesis and structure-activity relationship studies. Toolabi M; Moghimi S; Bakhshaiesh TO; Salarinejad S; Aghcheli A; Hasanvand Z; Nazeri E; Khalaj A; Esmaeili R; Foroumadi A Eur J Med Chem; 2020 Jan; 185():111786. PubMed ID: 31671308 [TBL] [Abstract][Full Text] [Related]
12. Design, synthesis and biological evaluation of novel 2,4-bismorpholinothieno[3,2-d]pyrimidine and 2-morpholinothieno[3,2-d]pyrimidinone derivatives as potent antitumor agents. Ye T; Han Y; Wang R; Yan P; Chen S; Hou Y; Zhao Y Bioorg Chem; 2020 Jun; 99():103796. PubMed ID: 32283346 [TBL] [Abstract][Full Text] [Related]
14. Synthesis and biological evaluation of novel 2,4,5-substituted pyrimidine derivatives for anticancer activity. Xie F; Zhao H; Zhao L; Lou L; Hu Y Bioorg Med Chem Lett; 2009 Jan; 19(1):275-8. PubMed ID: 19028425 [TBL] [Abstract][Full Text] [Related]
15. Synthesis and anti-tumor activities of some new pyridines and pyrazolo[1,5-a]pyrimidines. Ahmed OM; Mohamed MA; Ahmed RR; Ahmed SA Eur J Med Chem; 2009 Sep; 44(9):3519-23. PubMed ID: 19398146 [TBL] [Abstract][Full Text] [Related]
16. Synthesis of novel thiazolyl-pyrimidines and their anticancer activity in vitro. Shi HB; Li HB; Lu KQ; Zhu XR; Hu WX; Pei W Arch Pharm (Weinheim); 2011 Oct; 344(10):675-83. PubMed ID: 21984017 [TBL] [Abstract][Full Text] [Related]
17. Design, synthesis, anticancer activity and docking studies of novel 4-morpholino-7,8-dihydro-5H-thiopyrano[4,3-d]pyrimidine derivatives as mTOR inhibitors. Zhu W; Sun C; Xu S; Wu C; Wu J; Xu M; Zhao H; Chen L; Zeng W; Zheng P Bioorg Med Chem; 2014 Dec; 22(24):6746-54. PubMed ID: 25468038 [TBL] [Abstract][Full Text] [Related]
18. Design, synthesis and 3D-QSAR of beta-carboline derivatives as potent antitumor agents. Cao R; Guan X; Shi B; Chen Z; Ren Z; Peng W; Song H Eur J Med Chem; 2010 Jun; 45(6):2503-15. PubMed ID: 20304536 [TBL] [Abstract][Full Text] [Related]
19. An unexpected Dimroth rearrangement leading to annelated thieno[3,2-d][1,2,3]triazolo[1,5-a]pyrimidines with potent antitumor activity. Lauria A; Patella C; Abbate I; Martorana A; Almerico AM Eur J Med Chem; 2013 Jul; 65():381-8. PubMed ID: 23747807 [TBL] [Abstract][Full Text] [Related]
20. Synthesis and antitumor activity of pyrido [2,3-d]pyrimidine and pyrido[2,3-d] [1,2,4]triazolo[4,3-a]pyrimidine derivatives that induce apoptosis through G1 cell-cycle arrest. Fares M; Abou-Seri SM; Abdel-Aziz HA; Abbas SE; Youssef MM; Eladwy RA Eur J Med Chem; 2014 Aug; 83():155-66. PubMed ID: 24956552 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]